This study evaluated the diagnostic value of dynamic contrast-enhanced MRI (DCE-MRI) combined with 3D amide proton transfer weighted imaging (APTWI) for differentiation between benign and malignant breast masses. Results indicated the quantitative MTRasym(3.5 ppm) value calculated by APTWI was significantly different between benign and malignant lesions, and the combination of APTWI and DCE-MRI improves the diagnostic performance for discriminating benign and malignant breast masses, especially category 4 masses.
This abstract and the presentation materials are available to members only; a login is required.